Researchers at Brown University have developed a groundbreaking new opioid testing technology that has the potential to revolutionize modern medicine. This project was led by Dr. Ramisa Fariha of Bangladesh, who is currently working as a Postdoctoral Research Associate at Brown University. Under her leadership, this new technology opens a new horizon for fast and accurate testing of dangerous opioid use.
Currently, detecting opioid use often requires a large amount of blood, which can be challenging for many patients. The new technology developed by Dr. Ramisa Fariha and her team can perform the test with only 20 microliters of blood. As a result, this test can be made accessible to patients not only in major cities but also in developing countries.
This technology can detect opioids not only in liquid blood samples but also from dried blood spots, making it especially effective for determining opioid exposure in newborns. Through this, doctors will be able to accurately know the amount of opioids in a child’s body, which will help make significant improvements in treatment methods.
Dr. Fariha stated,
“We don’t want patients to undergo repeated testing; instead, our goal is to develop a method that is easier, faster, and more affordable for patients. Our aim is to create a process that can reach patients worldwide with ease.”
This is important not only for adults who use opioids but also for issues related to newborn and maternal health. This research at Brown University will undoubtedly open new horizons in medical care and play a role in changing the lives of millions of people around the world.
Source: https://www.brown.edu/news/2025-06-16/opioids
Dr. Fariha’s
This successful innovation will undoubtedly be considered a groundbreaking step in medical science.
Leave a comment